Nextmune US

What Nextmune US does

Nextmune US is the North American commercial entity of Nextmune, a specialty veterinary healthcare organization operating under Sweden-listed Vimian Group. The company focuses exclusively on companion animals (dogs and cats) and horses, with a vertically integrated portfolio spanning four therapeutic areas: allergy, dermatology, otology, and specialized nutrition. Its core proprietary platform is PAX (Pet Allergy Xplorer), a serum-based diagnostic that identifies specific allergen sensitivities in dogs, cats, and horses, enabling personalized allergen-specific immunotherapy that is also produced and supplied by the company. Surrounding the diagnostic-treatment pathway, Nextmune markets a broad branded product portfolio including the Dermoscent dermatology line (Atop-7, Essential 6, Pyo, BioBalm, Senior, AromaCalm), otology products (Otodine, Peptivet Oto, PyoClean Oto, Clorexyderm Oto), and condition-targeted nutritional supplements (Direne, Uti-Zen, Epato, Enteromicro Complex, Keravita, Dia-Tab, Stomek).

The business operates a dual-channel go-to-market: prescription and diagnostic products are distributed through veterinarians and veterinary practices who recommend and prescribe them, while non-prescription dermatology, ear care, hygiene, and nutritional products are also sold directly to pet parents via the company's e-commerce storefront and localized regional websites. Geographic reach is explicitly global, with localized websites and operations in at least ten countries spanning Europe, North America (US headquarters in Phoenix, AZ), and Oceania (Australia). The company employs 23 people in the US entity, was founded in 1989, and is privately held as a subsidiary of the Vimian Group. The revenue model combines one-time diagnostic kit sales, prescription recurring therapeutics (notably multi-year immunotherapy regimens), OTC consumer product sales, and subscription-style nutritional supplement revenue, though pricing is not publicly disclosed and is set through veterinary channels.

Name

Nextmune US

Legal name

Nextmune

Website

https://nextmune.us

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Nextmune US is the North American subsidiary of Nextmune, a Vimian Group–owned specialty animal health company offering allergy diagnostics (PAX), immunotherapy, dermatology, otology, and nutrition products for dogs, cats, and horses, sold through veterinarians and direct-to-consumer e-commerce.

Ownership category

akta.pro rank

Product category

Veterinary Specialty Healthcare (Pet Allergy, Dermatology, Otology, Nutrition)

NAICS

Pet and Pet Supplies Retailers (45991)

SIC

Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835), Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYHLAMAEAK

Biologics & Immunotherapies (Non-vaccine)

Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics

SECONDARYHLAMAEAH

Dermatology & Allergy Drugs

Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics

SECONDARYHLAMALAL

Allergy & Anti-Inflammatory Supplements

Healthcare & Life Sciences/Veterinary & Animal Health/Pet Supplements & Nutraceuticals

SECONDARYHLAMAIAH

Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology)

Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)

Keywords

• Veterinary diagnostics
• Pet allergy testing
• Veterinary dermatology
• Animal immunotherapy
• Pet nutrition supplements

Headquarters

HQ city

Not specified

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Diagnostic Testing Products: PAX allergy testing kits sold to veterinarians and pet parents for diagnostic purposes, enabling identification of allergen sensitivities in companion animals and horses
2. Prescription Therapeutics: Prescription medications and treatments including immunotherapy, dermatology products, and otology solutions sold through veterinary channels
3. Non-Prescription Consumer Products: Over-the-counter skin care, hygiene, ear cleaning, and nutritional supplements sold directly to pet parents through e-commerce and retail channels
4. Therapeutic Diets and Supplements: Specialized nutritional products for gut, liver, kidney, urinary, and skin/coat health conditions in companion animals

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Nextmune US develops, manufactures, and distributes specialty veterinary healthcare products for companion animals (dogs and cats) and horses across four therapeutic areas: allergy, dermatology, otology, and specialized nutrition. The portfolio is anchored by the proprietary PAX serum allergy diagnostic and customized allergen-specific immunotherapy, and extends to a broad range of topical, spot-on, shampoo, ear-care, and nutritional supplement products sold under brands including Dermoscent, PAX, Otodine, Peptivet, and Clorexyderm.

Product overview

Nextmune US offers a comprehensive portfolio of veterinary diagnostic and therapeutic products for companion animals (dogs and cats) and horses. The product suite is organized across four therapeutic areas: Allergy (including PAX allergy testing products and immunotherapy treatments), Dermatology (spanning topical treatments, shampoos, spot-ons, and balms under brands like Dermoscent), Otology (ear cleansers and treatments), and Specialized Nutrition (digestive supplements, liver/kidney/urinary support products). The PAX Allergy Xplorer diagnostics serve as the foundational testing tool enabling targeted immunotherapy and treatment selection. Key brands include Dermoscent (dermatology and otology), PAX (allergy diagnostics), and various condition-specific nutritional supplements.

Differentiator

Problem solved

Functional benefit

Brands

• PAX - Pet Allergy Xplorer: Serum test for pet allergy diagnostics
• Immunotherapy
• Dermoscent
• Clorexyderm
• Peptivet
• Otodine
• LinkSkin
• Allergone
• Ermidrà
• Dr. Baddaky Omega-3

Products and services

• PAX - Pet Allergy Xplorer (Serum Test)

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Vimian GroupcoreOthersVimian Group is the parent company of Nextmune. Nextmune operates as a division or brand under the Vimian Group umbrella, which is described as a sustainability-focused animal health company. The relationship provides Nextmune with corporate backing and alignment with Vimian's sustainability program in animal health.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Virbac: Global animal health company with a strong dermatology and specialty care franchise for companion animals, including shampoos, ear care, and topical dermatology products. Closely comparable to Nextmune across product categories, target customer (veterinarians), and global commercial structure.
• Ceva Santé Animale: Global animal health company with companion animal dermatology, behavior, and specialty pharmaceuticals. Comparable to Nextmune in mid-sized specialty pharma positioning, multi-region presence, and focus on pet-only therapeutic areas.
• Dechra Pharmaceuticals: Specialty veterinary pharmaceuticals company focused on companion animal endocrinology, dermatology, and supportive care. Directly comparable to Nextmune in niche specialty pharma positioning, with overlapping dermatology and supportive-care product lines distributed through vet channels.
• Vetoquinol: Independent animal health company with a strong companion-animal dermatology, otology, and supportive-care portfolio. Closely comparable to Nextmune in product mix (skin, ear, supplements) and European-rooted specialty distribution model.

Broad incumbents

• Elanco Animal Health: Major animal health company offering dermatology, parasiticides, and pharmaceuticals for companion animals and livestock. Competes with Nextmune in veterinary dermatology and prescription therapeutics, with materially larger US commercial scale.
• Phibro Animal Health: Diversified animal health and nutrition company with companion animal and livestock portfolios. Adjacent comparator due to its specialty nutritional supplements and animal health pharmaceuticals.
• Zoetis: The largest global animal health company with broad veterinary pharmaceutical, diagnostic, and dermatology portfolios including Apoquel and Cytopoint for allergic skin conditions. Comparable to Nextmune as a competitor in veterinary allergy/dermatology, but vastly larger and broader across species and therapeutic areas.
• IDEXX Laboratories: Leading veterinary diagnostics company offering allergy and specialty testing panels used by companion animal practices. Directly comparable to Nextmune's PAX diagnostic franchise, with much larger US lab network and integrated practice-software touchpoints.

Regional players

• Bayer Animal Health (now part of Elanco): Historically a global animal health major with companion animal dermatology and parasiticide lines (e.g., Advantage). Relevant as a historical specialty dermatology competitor; now absorbed into Elanco but its product set remains a comparator for Nextmune's dermatology franchise.

Emerging players

• Spectrum Veterinary: Specialty veterinary distributor focused on dermatology, allergy, and otology products for companion animal practices. Comparable to Nextmune as a niche specialty distributor overlapping on key product categories and veterinary-channel go-to-market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/nextmuneus

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nextmune US